- Home
- GERN vs ERII Comparison
GERN vs ERII Comparison
Compare GERN & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- ERII
- Stock Information
- Founded
- GERN 1990
- ERII 1992
- Country
- GERN United States
- ERII United States
- Employees
- GERN N/A
- ERII N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- ERII Industrial Machinery/Components
- Sector
- GERN Health Care
- ERII Technology
- Exchange
- GERN Nasdaq
- ERII Nasdaq
- Market Cap
- GERN 700.6M
- ERII 754.4M
- IPO Year
- GERN 1996
- ERII 2008
- Fundamental
- Price
- GERN $1.46
- ERII $14.73
- Analyst Decision
- GERN Buy
- ERII Buy
- Analyst Count
- GERN 8
- ERII 3
- Target Price
- GERN $3.71
- ERII $18.67
- AVG Volume (30 Days)
- GERN 12.0M
- ERII 453.7K
- Earning Date
- GERN 08-06-2025
- ERII 08-06-2025
- Dividend Yield
- GERN N/A
- ERII N/A
- EPS Growth
- GERN N/A
- ERII 25.10
- EPS
- GERN N/A
- ERII 0.43
- Revenue
- GERN $164,447,000.00
- ERII $141,775,000.00
- Revenue This Year
- GERN $159.14
- ERII $4.82
- Revenue Next Year
- GERN $52.76
- ERII $12.97
- P/E Ratio
- GERN N/A
- ERII $34.12
- Revenue Growth
- GERN 11877.20
- ERII 6.19
- 52 Week Low
- GERN $1.09
- ERII $10.86
- 52 Week High
- GERN $4.83
- ERII $20.27
- Technical
- Relative Strength Index (RSI)
- GERN 59.63
- ERII 61.64
- Support Level
- GERN $1.26
- ERII $14.00
- Resistance Level
- GERN $1.55
- ERII $14.55
- Average True Range (ATR)
- GERN 0.09
- ERII 0.46
- MACD
- GERN 0.02
- ERII 0.02
- Stochastic Oscillator
- GERN 75.00
- ERII 72.73
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.